Zenas BioPharma (ZBIO) Share-based Compensation (IS) (2024 - 2026)
Zenas BioPharma (ZBIO) recorded Share-based Compensation (IS) of $8.62 million in Q2 2026, up 42.6% from $6.05 million a year earlier but down 6.3% from the prior quarter.
Powered by 
Analysis
Zenas BioPharma (ZBIO) Share-based Compensation (IS) (2024 - 2026) Analysis & Trends
On a TTM basis, Zenas BioPharma's Share-based Compensation (IS) came in at $32.73 million as of Jun 30, 2026, up 65.6% year-over-year; for FY2025, it was $26.35 million, up 143.5% from FY2024.
- Across earlier years, Share-based Compensation (IS) came in at $10.82 million in FY2024 (+209.6%) and $3.5 million in FY2023.
- Quarterly Share-based Compensation (IS) has ranged from $947,000 in Q1 2024 to $9.2 million in Q1 2026 over the past five years.
- On a year-over-year basis, Share-based Compensation (IS) has increased for six consecutive quarters, with growth averaging 178.6% over the last six quarters.
- Per Business Quant, the preceding three quarters came in at $9.2 million (Q1 2026), $7.58 million (Q4 2025) and $7.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Zenas BioPharma | 1.77 Bn | 1.09 Bn | - | 8.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.62 Mn |
| Mar 31, 2026 | 9.20 Mn |
| Dec 31, 2025 | 7.58 Mn |
| Sep 30, 2025 | 7.34 Mn |
| Jun 30, 2025 | 6.05 Mn |
| Mar 31, 2025 | 5.39 Mn |
| Dec 31, 2024 | 5.50 Mn |
| Sep 30, 2024 | 2.84 Mn |
| Jun 30, 2024 | 1.54 Mn |
| Mar 31, 2024 | 947,000.00 |
API Access
Zenas BioPharma Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ZBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "ZBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=ZBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();